Perc Assist
Medical Devices, 2374 Walsh Ave, Santa Clara, California, 95051, United States, 1-10 Employees
Who is PERCASSIST
PercAssist technology is designed for hemodynamic support and cardiac recovery with simplicity, performance, and ease of use in mind for the patient and the clinician. The PercAssist proc...
Read More
- Headquarters: 2374 Walsh Ave, Santa Clara, California, 95051, United States
- Date Founded: 2019
- Employees: 1-10
- Revenue: Under $1 Million
- Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841 | NAICS Code: 339112 | Show More
Does something look wrong? Fix it. | View contact records from PERCASSIST
PercAssist Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PercAssist
Answer: PercAssist's headquarters are located at 2374 Walsh Ave, Santa Clara, California, 95051, United States
Answer: PercAssist's official website is https://percassist-corp.com
Answer: PercAssist's revenue is Under $1 Million
Answer: PercAssist's SIC: 3841
Answer: PercAssist's NAICS: 339112
Answer: PercAssist has 1-10 employees
Answer: PercAssist is in Medical Devices
Answer: PercAssist contact info: Phone number: Website: https://percassist-corp.com
Answer: PercAssist technology is designed for hemodynamic support and cardiac recovery with simplicity, performance, and ease of use in mind for the patient and the clinician. The PercAssist procedure is designed using a minimally invasive technique performed in the catheterization or hybrid lab. Proprietary ECG and implant technology applies ventricular compression synchronized with the patients natural heart rhythm. The implant does not reside in the bloodstream, reducing the possibility of anticoagulation therapy and the minimally invasive nature of the procedure is expected to shorten patient recovery time. Initial use is anticipated in emergent conditions such as cardiogenic shock and severe acute decompensated heart failure. Future use is anticipated in longer-term support of advanced heart failure patients including bridge to transplant or destination therapy. Caution: The PercAssist technology is under development and is for investigational use only. Not approved by FDA and not available for commercial distribution in the United States or any other market.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month